W. Wober

593 total citations
23 papers, 486 citations indexed

About

W. Wober is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, W. Wober has authored 23 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in W. Wober's work include Inflammatory mediators and NSAID effects (5 papers), Allergic Rhinitis and Sensitization (4 papers) and Asthma and respiratory diseases (4 papers). W. Wober is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Allergic Rhinitis and Sensitization (4 papers) and Asthma and respiratory diseases (4 papers). W. Wober collaborates with scholars based in Germany, United States and France. W. Wober's co-authors include Christian Weber, Petar Alaupovic, O. W. Thiele, Reinhard Lorenz, W. Küpper, W. Bleifeld, Christian W. Hamm, Susan M. Fischer, B. Urbaschek and A. Macciocchi and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Journal of Biochemistry.

In The Last Decade

W. Wober

23 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Wober Germany 12 148 116 90 79 75 23 486
G. Andrioli Italy 14 178 1.2× 132 1.1× 114 1.3× 95 1.2× 84 1.1× 21 718
P J Kerry United Kingdom 11 32 0.2× 88 0.8× 68 0.8× 41 0.5× 37 0.5× 27 344
Cihan Örem Türkiye 16 224 1.5× 83 0.7× 19 0.2× 36 0.5× 137 1.8× 46 639
Aprilfawn White Switzerland 12 71 0.5× 293 2.5× 56 0.6× 39 0.5× 42 0.6× 22 625
Agnes G. van Velzen Netherlands 8 52 0.4× 145 1.3× 20 0.2× 137 1.7× 65 0.9× 14 494
Dilip Kumar Roy India 11 66 0.4× 145 1.3× 35 0.4× 154 1.9× 217 2.9× 23 595
D A Lichti United States 7 52 0.4× 79 0.7× 20 0.2× 80 1.0× 118 1.6× 10 477
Tzeng‐Fu Chen Taiwan 10 40 0.3× 122 1.1× 57 0.6× 20 0.3× 38 0.5× 14 398
Ryo Nakamura Japan 13 167 1.1× 123 1.1× 11 0.1× 89 1.1× 61 0.8× 47 552

Countries citing papers authored by W. Wober

Since Specialization
Citations

This map shows the geographic impact of W. Wober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Wober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Wober more than expected).

Fields of papers citing papers by W. Wober

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Wober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Wober. The network helps show where W. Wober may publish in the future.

Co-authorship network of co-authors of W. Wober

This figure shows the co-authorship network connecting the top 25 collaborators of W. Wober. A scholar is included among the top collaborators of W. Wober based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Wober. W. Wober is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
3.
Wober, W., et al.. (1997). Efficacy and Tolerability of Azelastine Nasal Spray in the Treatment of Allergic Rhinitis: Large Scale Experience in Community Practice. Current Medical Research and Opinion. 13(10). 617–626. 8 indexed citations
4.
Wober, W., et al.. (1997). Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.. PubMed. 47(7). 841–4. 10 indexed citations
5.
Zimmermann, Holger, et al.. (1996). [Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal].. PubMed. 51(8). 608–10. 2 indexed citations
6.
Wober, W., et al.. (1996). Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray -non-sedating in children. Current Medical Research and Opinion. 13(7). 391–395. 11 indexed citations
7.
Hamm, Christian W., Reinhard Lorenz, W. Bleifeld, et al.. (1987). Biochemical evidence of platelet activation in patients with persistent unstable angina. Journal of the American College of Cardiology. 10(5). 998–1004. 144 indexed citations
8.
Hoeft, Andreas, et al.. (1986). Preservation of myocardium in transient ischemia by the thromboxane synthetase inhibitor UK 38.485. Research in Experimental Medicine. 186(1). 35–46. 7 indexed citations
9.
Korb, H., et al.. (1986). Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.. PubMed. 36(7). 1040–4. 1 indexed citations
10.
Lorenz, Reinhard, et al.. (1986). Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in man. Biochemical Pharmacology. 35(5). 761–766. 16 indexed citations
11.
Korb, H., Andreas Hoeft, D. H. Hunneman, et al.. (1984). Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine]. Naunyn-Schmiedeberg s Archives of Pharmacology. 327(1). 70–74. 13 indexed citations
12.
13.
Wahn, Ulrich, et al.. (1978). [Beclomethasone dipropionate seasonal allergic rhinitis treatment of children. A double blind cross over study (author's transl)].. PubMed. 126(3). 133–5. 2 indexed citations
14.
Dahlheim, H., et al.. (1974). [Renin, angiotensin II, catecholamines and blood pressure in healthy subjects and in patients with essential hypertension prior and following beta-blockade].. PubMed. 80. 215–8. 2 indexed citations
15.
Wober, W. & Petar Alaupovic. (1971). Studies on the Protein Moiety of Endotoxin from Gram‐Negative Bacteria. European Journal of Biochemistry. 19(3). 340–356. 47 indexed citations
16.
Wober, W. & O. W. Thiele. (1966). Trennung phosphorhaltiger Abbauprodukte von Phosphatiden auf Celluloseplatten. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 116(1). 163–166. 22 indexed citations
17.
Thiele, O. W. & W. Wober. (1964). Präparative dünnschichtchromatographische Trennung von Phosphatiden und dünnschichtchromatographischer Nachweis ihrer Hydrolyseprodukte. Angewandte Chemie. 76(15). 690–690. 4 indexed citations
18.
Thiele, O. W. & W. Wober. (1964). Präparative dünnschichtchromatographische Trennung von Phosphatiden und dünnschichtchromatographischer Nachweis ihrer Hydrolyseprodukte. Fresenius Zeitschrift für Analytische Chemie. 205(1). 442–445. 7 indexed citations
19.
Thiele, O. W., W. Wober, & B. Urbaschek. (1962). Zur Biochemie des blutgruppenspezifischen J-Haptens aus Rinderserum. Die Naturwissenschaften. 49(9). 208–209. 5 indexed citations
20.
Thiele, O. W. & W. Wober. (1961). Zur papierchromatographischen Trennung von Phosphatiden auf einem neuartigen Kieselgelpapier. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 326(Jahresband). 89–93. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026